Fairhaven Wealth Management, LLC Abb Vie Inc. Transaction History

Fairhaven Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $247,726 - $307,358	-1,877 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$106.4 - $120.78 $5,745 - $6,522	-54 Reduced 2.8%	1,877 $202,000
Q2 2021 Aug 09, 2021	SELL	$105.21 - $117.21 $841 - $937	-8 Reduced 0.41%	1,931 $218,000
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $818 - $900	8 Added 0.41%	1,939 $210,000
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $155,426 - $209,841	1,931 New	1,931 $207,000

3,773

1.28B

13M

9.82M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $354B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Fairhaven Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fairhaven Wealth Management, LLC with notifications on news.